Chronic Kidney Disease and Subclinical Brain Infarction Increase the Risk of Vascular Cognitive Impairment: The Sefuri Study

Background and Purpose The purpose of this study was to determine the complex associations among chronic kidney disease (CKD), subclinical brain infarction (SBI), and cognitive impairment. Methods We used structural equation modeling (SEM) to examine the complex relationships among CKD, SBI, and cog...

Full description

Saved in:
Bibliographic Details
Published inJournal of stroke and cerebrovascular diseases Vol. 26; no. 2; pp. 420 - 424
Main Authors Yao, Hiroshi, MD, PhD, Araki, Yuko, PhD, Takashima, Yuki, MD, PhD, Uchino, Akira, MD, PhD, Yuzuriha, Takefumi, MD, PhD, Hashimoto, Manabu, MD, PhD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.02.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background and Purpose The purpose of this study was to determine the complex associations among chronic kidney disease (CKD), subclinical brain infarction (SBI), and cognitive impairment. Methods We used structural equation modeling (SEM) to examine the complex relationships among CKD, SBI, and cognitive function with Mini-Mental State Examination (MMSE; global function) and modified Stroop test (executive function) in a population-based cohort of 560 non-demented elderly subjects. Results Path analysis based on SEM revealed that the direct paths from estimated glomerular filtration rate (eGFR) to SBI and from SBI to executive function were significant (β = −.10, P  = .027, and β = .16, P  < .001, respectively). Furthermore, the direct path from eGFR to executive function was also significant (β = −.12, P  = .006), indicating that the effects of CKD on executive function are independent of SBI. The direct paths from age and education to global cognitive function were highly significant (β = −.17 and .22, respectively, P  < .001), whereas the direct path from eGFR to MMSE was not significant. Conclusions Our findings indicate that CKD confers a risk of vascular cognitive impairment or executive dysfunction through mechanisms dependent and independent of SBI. Treating CKD may be a potential strategy to protect against vascular cognitive impairment or executive dysfunction in healthy elderly subjects.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ISSN:1052-3057
1532-8511
DOI:10.1016/j.jstrokecerebrovasdis.2016.10.002